Northwestern University — Cancer Nanotechnology Training Program
Principal Investigator: Gayle Woloschak, Ph.D.
Training Focus and Objectives
The goal of this program is to train MD- and PhD-level investigators (up to 4 per year) in the principles and tools of nanotechnology, cancer biology, and clinical oncology with the eventual goal of applying these skills to translational research that impacts cancer patients. The training program offers a well-rounded curriculum with basic courses, career development programs, and research-based experiences that is designed around the needs of each of the trainees. Training includes many nanotechnology resources including NU's International Institute for Nanotechnology, the Institute for BioNanotechnology, and the NU CCNE. Faculty from each of these centers participate in our T32 program. Fellows enrolled in the training program will acquire the skills and knowledge to design cancer nanomaterials, to investigate their biological properties, and to evaluate their safety and efficacy.